Sign inJoin waitlistJoin the waitlist

Ann Partridge

Physician · Dana-Farber Cancer Institute

Credentials: · · · ·

History

Dana-Farber Cancer Institute
Present

Hematology and Medical Oncology
Dana-Farber Cancer Institute
1998–2001
University of Pennsylvania School of Medicine
1995–1998
Harvard School of Public Health
Weill Cornell Medicine
1991–1995
Georgetown University

Research

American Society of Clinical Oncology recommendations on fertility preservation in cancer patients
Systematic review or meta-analysis · Journal of Clinical Oncology · 2006 · 1,433 citations
Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update
Systematic review or meta-analysis · Journal of Clinical Oncology · 2013 · 1,176 citations
Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update
Systematic review or meta-analysis · Journal of Clinical Oncology · 2018 · 1,160 citations

Eric Winer
122 papers
Kathryn Ruddy
111 papers · 5 as a fellow
Virginia Borges
63 papers
Lidia Schapira
61 papers
Steven Come
58 papers
Lisa Carey
49 papers
Sara Tolaney
46 papers · 1 as a fellow
Jeffrey Peppercorn
43 papers · 1 as a fellow
Harold Burstein
34 papers · 2 as a fellow
Philip Poorvu
34 papers · 3 as a fellow
Shari Gelber
32 papers · 3 as a resident
IK
Ian Krop
29 papers

Grants

A Web-Based Patient-Reported Symptom Monitoring and Self-Management Portal for Adolescent and Young Adult Breast Cancer Survivors
National Cancer Institute · U01
Contact PI · $3.7M · Dana-Farber Cancer Inst
2020–2025
Young and Strong a Program for Yound Women with Breast Cancer
NCCDPHP · U58
Contact PI · $350K · Dana-Farber Cancer Inst
2014–2019
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $15.4K · Brigham and Women's Hospital
2006–2008

Clinical trials

Supporting Health Including Endocrine Treatment for Long Duration
Principal investigator · Recruiting
Dana-Farber Cancer Institute
2026–2027
INTENT Pilot Study - Enhancing Adherence Intentions to Endocrine Therapy
Principal investigator · Completed
Dana-Farber Cancer Institute
2024
YES Study - Newly Diagnosed/Metastatic Intervention
Principal investigator · Active not recruiting
Dana-Farber Cancer Institute
2020–2028
Young, Empowered & Strong (YES): The Young Women's Breast Cancer Study 2- Focus on Intervention Pilot
Principal investigator · Completed
Dana-Farber Cancer Institute
2019